GlassScriptPhysician profile
Elana Richter
NPI 1376070706
$472.67
in general payments reported to CMS, 2019-2025
14 companies · $86.92 in 2025
The $86.92 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.68 · 2022: $207 · 2023: $53.39 · 2024: $46.19 · 2025: $86.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $87.42 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $64.97 | 2021-2023 | Vaxelis, M-M-R II, Gardasil 9 |
| Cranial Technologies, INC | $41.84 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $35.17 | 2022 | |
| Tris Pharma INC | $32.94 | 2022 | |
| Corium, LLC | $32.47 | 2024 | Azstarys |
| Collegium Pharmaceutical, INC. | $31.31 | 2025 | Jornay Pm |
| Phadia US INC. | $29.19 | 2022-2024 | Immunocap |
| Glaxosmithkline, LLC. | $27.97 | 2022 | |
| Neurocrine Biosciences, INC. | $22.98 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.40 | 2023 | Flumist Quadrivalent |
| Bavarian Nordic A/S | $18.69 | 2025 | Vivotif |
| Ironshore Pharmaceuticals INC. | $13.79 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elana Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.